Skip to content
Disclosery

Sands Capital Alternatives, LLC

Follow

13F filer, CIK 1846444, ARLINGTON, VA

Sands Capital Alternatives, LLC reported $421,198,307 across 21 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-08. Its ten largest share positions make up 86.97% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001846444-26-000005

Period
2026-03-31
Reported value
$421M
Holdings
21
Top 10 weight
86.97%
New
1
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SGPnew+2,500,012$64.8M
IOTadded+94,097$2.98M
CPNGadded+141,667$2.67M
DASHadded+15,613$2.34M
BBNXadded+137,930$1.38M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
NUreduced-323,630-$4.65M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001846444-26-000005, largest first. % of portfolio is the value over $421,198,307, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NUNU HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 5,498,802 shares; 2024Q4: 7,021,159 shares; 2025Q1: 7,164,355 shares; 2025Q2: 7,175,434 shares; 2025Q3: 7,175,434 shares; 2025Q4: 6,861,399 shares; 2026Q1: 6,537,769 shares 6,537,769$93.9M22.3%-323,630Timeline
KVYOKLAVIYO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,515,325 shares; 2024Q4: 3,470,694 shares; 2025Q1: 3,443,515 shares; 2025Q2: 3,515,065 shares; 2025Q3: 3,515,065 shares; 2025Q4: 3,649,678 shares; 2026Q1: 3,649,678 shares 3,649,678$71M16.86%0Timeline
SGPSPYGLASS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,500,012 shares 2,500,012$64.8M15.38%newTimeline
BBNXBETA BIONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,103,782 shares; 2025Q2: 3,570,113 shares; 2025Q3: 3,570,113 shares; 2025Q4: 3,570,113 shares; 2026Q1: 3,708,043 shares 3,708,043$37.2M8.82%+137,930Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 10,950,000 shares; 2025Q1: 10,950,000 shares; 2025Q2: 10,950,000 shares; 2025Q3: 10,950,000 shares; 2025Q4: 13,018,965 shares; 2026Q1: 13,018,965 shares 13,018,965$21.9M5.19%0Timeline
CPNGCOUPANG INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 11,931 shares; 2024Q4: 924,712 shares; 2025Q1: 843,476 shares; 2025Q2: 849,031 shares; 2025Q3: 795,006 shares; 2025Q4: 870,424 shares; 2026Q1: 1,012,091 shares 1,012,091$19.1M4.54%+141,667Timeline
IOTSAMSARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,172 shares; 2024Q4: 198,690 shares; 2025Q1: 253,432 shares; 2025Q2: 438,485 shares; 2025Q3: 598,914 shares; 2025Q4: 466,190 shares; 2026Q1: 560,287 shares 560,287$17.8M4.22%+94,097Timeline
DASHDOORDASH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 423,338 shares; 2024Q4: 407,343 shares; 2025Q1: 380,704 shares; 2025Q2: 381,202 shares; 2025Q3: 90,142 shares; 2025Q4: 95,618 shares; 2026Q1: 111,231 shares 111,231$16.7M3.97%+15,613Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,086,353 shares; 2024Q4: 786,353 shares; 2025Q1: 786,353 shares; 2025Q2: 786,353 shares; 2025Q3: 786,353 shares; 2025Q4: 786,353 shares; 2026Q1: 786,353 shares 786,353$13.8M3.27%0Timeline
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 481,770 shares; 2024Q4: 481,770 shares; 2025Q1: 481,770 shares; 2025Q2: 481,770 shares; 2025Q3: 481,770 shares; 2025Q4: 481,770 shares; 2026Q1: 481,770 shares 481,770$10.2M2.43%0Timeline
DDOGDATADOG INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,406 shares; 2024Q4: 97,788 shares; 2025Q1: 117,930 shares; 2025Q2: 118,707 shares; 2025Q3: 118,707 shares; 2025Q4: 85,793 shares; 2026Q1: 85,793 shares 85,793$10.1M2.4%0Timeline
ABOSACUMEN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,417,075 shares; 2024Q4: 3,417,075 shares; 2025Q1: 3,417,075 shares; 2025Q2: 3,417,075 shares; 2025Q3: 3,417,075 shares; 2025Q4: 3,417,075 shares; 2026Q1: 3,720,105 shares 3,720,105$8.78M2.08%+303,030Timeline
TOSTTOAST INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,453 shares; 2024Q4: 231,530 shares; 2025Q1: 210,611 shares; 2025Q2: 156,604 shares; 2025Q3: 156,604 shares; 2025Q4: 301,647 shares; 2026Q1: 301,647 shares 301,647$8M1.9%0Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 170,000 shares; 2024Q4: 170,000 shares; 2025Q1: 170,000 shares; 2025Q2: 170,000 shares; 2025Q3: 170,000 shares; 2025Q4: 85,000 shares; 2026Q1: 85,000 shares 85,000$5.96M1.42%0Timeline
TTANSERVICETITAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 89,856 shares; 2026Q1: 89,856 shares 89,856$5.7M1.35%0Timeline
MNDYMONDAY COM LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 48,278 shares; 2025Q1: 49,908 shares; 2025Q2: 58,336 shares; 2025Q3: 58,336 shares; 2025Q4: 67,868 shares; 2026Q1: 67,868 shares 67,868$4.69M1.11%0Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 724,873 shares; 2024Q4: 724,873 shares; 2025Q1: 724,873 shares; 2025Q2: 724,873 shares; 2025Q3: 724,873 shares; 2025Q4: 724,873 shares; 2026Q1: 724,873 shares 724,873$3.24M0.77%0Timeline
SNOWSNOWFLAKE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 108,304 shares; 2024Q4: 39,007 shares; 2025Q1: 26,828 shares; 2025Q2: 27,005 shares; 2025Q3: 27,005 shares; 2025Q4: 20,253 shares; 2026Q1: 20,253 shares 20,253$3.05M0.73%0Timeline
ACRVACRIVON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,122,605 shares; 2024Q4: 2,122,605 shares; 2025Q1: 2,122,605 shares; 2025Q2: 2,122,605 shares; 2025Q3: 2,122,605 shares; 2025Q4: 2,122,605 shares; 2026Q1: 2,122,605 shares 2,122,605$2.95M0.7%0Timeline
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 405,837 shares; 2024Q4: 405,837 shares; 2025Q1: 405,837 shares; 2025Q2: 405,837 shares; 2025Q3: 405,837 shares; 2025Q4: 405,837 shares; 2026Q1: 405,837 shares 405,837$1.99M0.47%0Timeline
FIGFIGMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,286 shares; 2025Q4: 18,286 shares; 2026Q1: 18,286 shares 18,286$387K0.09%0Timeline

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001846444-26-000005 base2026-05-08acceptance time not in the bulk data set